Skip to main content

Table 1 Socio-Demographic and Comorbidity Characteristics of Individuals who Tested Positive (n = 12,084) for SARS-CoV-2, by Race and Ethnicity, at Houston Methodist through July 18th, 2020

From: Disparities in COVID-19 hospitalizations and mortality among black and Hispanic patients: cross-sectional analysis from the greater Houston metropolitan area

 

Non-Hispanic White

(n = 3346)

Non-Hispanic Black

(n = 3049)

Non-Hispanic

(n = 7348)

Hispanic

(n = 4372)

Demographics – n (%)

Age – mean (SD)

51.7 (20.1)

46.0 (18.1) a

48.7 (19.2)

44.0 (17.4) a

Age ≤ 50

1582 (47.3)

1825 (59.9) a

4008 (54.5)

3340 (76.4) a

Females

1792 (53.6)

1837 (60.2) a

4164 (56.7)

2398 (54.8)

Insurance Type

 Commercial

1736 (51.9)

1454 (47.7) a

3738 (50.9)

1911 (43.7) a

 Medicare

892 (26.7)

567 (18.6)

1605 (21.8)

574 (13.1)

 Medicaid

98 (2.9)

227 (7.4)

349 (4.7)

380 (8.7)

 Self-Pay

507 (15.2)

729 (23.9)

1449 (19.7)

1452 (33.2)

 Other

113 (3.4)

72 (2.4)

207 (2.8)

55 (1.3)

Household Income (USD), Median (IQR)

75,793 (59,104 – 102,008)

63,489 (46,801 – 76,163) a

68,318 (52,825 – 97,681)

59,104 (46,300 – 75,793) a

Population Density (per square mile), Median (IQR)

2741.6 (1162.5–4264.5)

3256.8 (2040.7–4575) a

2883.9 (1504–4384.8)

3380.9 (1683.5–4384.8) a

Coexisting Conditions / Prior Vaccinations – n (%)

CCI Total, Median (IQR)

2 (0–4)

1 (0–3) a

1 (0–4)

1 (0–2) a

Charlson Comorbidities – n (%)

 Myocardial Infarction

263 (7.9)

224 (7.3)

530 (7.2)

156 (3.6) a

 Congestive Heart Failure

334 (10.0)

328 (10.8)

711 (9.7)

202 (4.6) a

 Peripheral Vascular Disease

328 (9.8)

200 (6.6) a

570 (7.8)

182 (4.2) a

 CVA / TIA

294 (8.8)

259 (8.5)

599 (8.2)

186 (4.3) a

 Dementia

179 (5.3)

115 (3.8) a

317 (4.3)

41 (0.9) a

 COPD

712 (21.3)

589 (19.3)

1409 (19.2)

465 (10.6) a

 Connective Tissue Disease

91 (2.7)

72 (2.4)

177 (2.4)

71 (1.6) a

 Peptic Ulcer

83 (2.5)

51 (1.7) a

147 (2.0)

58 (1.3) a

 Liver Disease (Mild)

238 (7.1)

123 (4.0) a

410 (5.6)

224 (5.1)

 Liver Disease (Moderate to Severe)

34 (1.0)

12 (0.4) a

48 (0.7)

34 (0.8)

 Diabetes w/o Complications

590 (17.6)

769 (25.2) a

1541 (21.0)

978 (22.4)

 Diabetes with Complications

199 (5.9)

293 (9.6) a

538 (7.3)

219 (5.0) a

 Hemiplegia

40 (1.2)

40 (1.3)

87 (1.2)

27 (0.6) a

 CKD (Mild to Moderate)

109 (3.3)

152 (5.0) a

283 (3.9)

155 (3.5)

 Solid Tumor (Localized)

278 (8.3)

131 (4.3) a

438 (6.0)

132 (3.0) a

 Solid Tumor (Metastatic)

214 (6.4)

97 (3.2) a

331 (4.5)

99 (2.3) a

 AIDS

14 (0.4)

41 (1.3) a

56 (0.8)

15 (0.3) a

 BMI – mean (SD)

29.8 (7.2)

32.2 (8.2) a

30.6 (7.7)

31.7 (7.4) a

 Obesity

777 (23.2)

721 (23.6)

1614 (22.0)

808 (18.5) a

 Hypertension

1441 (43.1)

1454 (47.7) a

3197 (43.5)

1380 (31.6) a

 Hyperlipidemia

1093 (32.7)

826 (27.1) a

2182 (19.7)

925 (21.2) a

 Asthma

374 (11.2)

365 (12.0)

811 (11.0)

270 (6.2) a

 Smoking (Current/Former)

829 (24.8)

577 (18.9) a

1509 (20.5)

607 (13.9) a

Prior Vaccinationb

 Influenza

424/626 (67.7)

370/650 (56.9) a

861/1382 (62.3)

322/544 (59.2) a

 Pneumonia

527/1064 (49.5)

396/1047 (37.8) a

996/2323 (42.9)

353/1191 (29.6) a

Hospitalized

966 (28.9)

937 (30.7)

2115 (28.8)

1366 (31.2) a

  1. CCI Charlson Comorbidity Index, IQR Interquartile Range, CVA / TIA Cerebrovascular Accident / Transient Ischemic Attack
  2. a p < 0.05
  3. b Denominator denotes number of non-missing values
  4. Excluding missing data:
  5. Ethnicity (n = 364)
  6. Median Household Income (n = 86)
  7. Population Density (n = 77)